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In some of the earliest experiments proving the existence of crossreactive idio-
types (CRIs), Kunkel et al. (1) prepared adult rabbit antiidiotypic antibodies that
recognized setsofcold agglutinins (CAs)or rheumatoid factors (RFs) from unrelated
individuals. The Wa group represents the largest ofthe RFassociated CRIs. These
RFs use L chains of the minor VkIIIb variable region sub-subgroup. The complete
sequence of the 12 Wa CRI+ RF L chains that have been reported are extremely
homologous, and are considered to be the products ofa conserved germline Vk gene,
termed Humkv325 (reviewed in reference 2). The products of this gene are identified
with antibodies directed against synthetic peptides homologous to the second (anti-
PSL2) and third (anti-PSL3) complementarity determining regions (CDRs) of the
L chain of the Wa+ IgM-RF Sie. Also, by correlation of immunoreactivity with
Southern blotting and DNA sequencing, the murine monoclonal anti-CRI antibody,
17.109, has been shown to identify a discontinuous idiotype present on intact Igs
or isolated L chains derived from genes identical or nearly identical to the germline
configuration of Humkv325 (3).
CRIs associated with the L and H chains ofCAs have also been described (reviewed
in reference 4). Many CAs bind to the I antigen, a developmentally regulated carbo-
hydrate moiety on the erythrocyte membrane (5). The CAs with anti-I specificity
generally use VkIII L chains, which may also derive from the Humkv325 gene and/or
closely related genes (2, 6). As both RFs and CAs frequently use the same Humkv325-
derived L chains, we reasoned that the two types of autoantibodies should display
quite distinct patterns of H chain use. To test this hypothesis, we used synthetic pep-
tides to generate primary sequence-dependent antibodies specific for the three major
human VH protein subgroups (7). Initial studies ofRFs from unrelated individuals
revealed that Humkv325-derived antibodies often express anti-IgG activity when
paired with a subset of VHI H chains (7). In marked contrast, the present results
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show that anti-I CAs with Humkv325-linked idiotypic markers all use H chains of
the minor VHII subgroup. Furthermore, four other antierythrocyte antibodieswith
VkIII L chains display the same VH subgroup restriction.
Materials and Methods
Human Monoclonal CAs andRFs.
￿
CAs were isolated from the sera ofpatients with chronic
cold agglutinin disease. The paraproteins Soc, Pos, Kau, and Tri were kindly provided by
Dr. J . Oppenheim (New York University, New York, NY). Bat, Bon, Hig, Lea, and Per were
donated by W. F. Rosse (Duke University, Durham, NC), and AJ was provided by R. C.
Williams, Jr. (University of New Mexico, Albuquerque, NM). CA activity was confirmed
using adult human O' erythrocytes at 4°C, as described (5). All CAs were found to bind
I antigen and not i, or other red cell epitopes (5), and were devoid of cryoglobulin or RF
activity by latex fixation.
The monoclonal RF cryoglobulins and CAs were purified from serum as described previ-
ously (5, 8). CA activity was undetectable in RF samples at dilutions >1 :16.
Antipeptide Antisera.
￿
Synthetic peptides were kindly provided by R. Houghten (Scripps
Clinic, La Jolla, CA). Siteswere selected from the NHz-terminal end of the constant regions
of x and uchains about a 0 bend, representing the sequences VFIFPPSDEQLKSGTASVVC
and SASAPTLFPLVSC (one-letter amino acid code), respectively. Other previously described
peptides correspond to portions of first framework regions that are diagnostic for the four
x subgroups (9) and three major H chain subgroups (7). The PHI and PHIII peptides used
to generate the VHI and III subgroup reagents represent consensus sequences, AEVKKP-
GASVKVSC and GGLVQPGGSLRLSC, respectively. The PHII peptide, PGLVKPSE-
TLSLTC, which was used to generate the subgroup II antibody, was taken directly from the
homologous portion ofthe translated mRNAsequence of the B cell line V71.2. This H chain
was initially thought to derive from the VHII gene family, but more recently has been as-
signed to the newly described VHIV gene family (10) . The PSL2 and PSL3 peptides cor-
respond, respectively, to the second and third CDR, with adjacent framework regions, of
the L chain, of the IgM-RF Sie (2). All synthetic peptides were conjugatedto keyhole limpet
hemocyanin for immunization of 6-wk-old female NZW rabbits, as described (7, 9).
Subgroup and IdioypicAnalysis.
￿
The specificity ofthe peptide-induced antisera was demon-
strated by immunoblot analysis of proteins of known sequence, combined with peptide inhi-
bition studies, as previously described (7, 9). Briefly, the H and L chains of CAs and RFs
were electrophoretically separated on 10% polyacrylamide gels containing 0.1% SDS under
reducing conditions (7). After transfer ofthe proteins to nitrocellulose membranes, nonspecific
binding sites were blocked with Wo powdered milk in borate buffered saline, pH 8.2 (BBS).
Replicate blots with separated H and L chains were reacted with individual peptide-induced
antisera, or with control rabbit anti-Ig. After washing and incubation with 'III-protein A
(New England Nuclear, Boston, MA), reactive bands were detected by autoradiography, after
exposure of the blots to XAR film at -70°C for 24-72 h.
Results and Discussion
Immunoblotting was used to compare the L and H chain variable region sub-
groups, and the idiotypes, of purified CAs with anti-I activity, and of monoclonal
RFs. Displayed in Fig. 1, left, is a representative immunoblot that includes five CAs
(Per, Bat, Bon, Hig, Lea), and three RFs (Bor, Les, Riv). All eight L chains are
recognized by the VkIII-specific antibody. In a parallel experiment, none were rec-
ognized by the VkI, VkII, VkIV, or %-specific reagents (not shown). Within these
eight VkIII L chains, seven are reactive with the PSL2-induced anti-CRI, while
two (BATCA and BORRF) also bind the Humkv325-specific marker, anti-PSL3.
The immunoblotting results of 10 CAs, and of 30 RFs, are compiled in Table I (present
data and reference 7). Ofthe 10 VkIII CAs, four (BAT, KAU, POS, TRI) probably
derive from the Humkv325 gene, as they bear both the anti-PSL2 and PSL3 CRIB.SILVERMAN ET AL .
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Immunoblot analysis ofmonoclonal IgM-GAsand IgM-RFs. (Left) AfterSDS-PAGE
separation and transfer to nitrocellulose, replicateblots oftheLchains offive IgM-CAsand three
IgM-RFswere reacted with the indicated antipeptide antibodies. (') VkIIIa Lchains by amino
acid sequence comparison, and/or reactivity with the6B6.6 CRI (11). (Right)The reactivity of
H chains of 10 IgM-CAs and 10 IgM-RFs are displayed.
Additionally, by serologic and amino acid analysis, twoCA (AJ, SOC) also derive
from the Humkv325 gene. All 30 RFs in Table I are identified as probable products
oftheHumkv325 gene, based upon either reactivity with the anti-PSL3 and/or 17.109
antibodies, or amino acid sequence analysis .
Fig. 1, right, shows another representative immunoblot with 10 VkIII CAs and
eightHumkv325-derived RFs, which were probed with theanti-H chain antibodies.
Two VkIIIa-RFs (Les and Riv) are included forcomparison. As compiled in Table
I, all CAs and 29:30 Humkv325-derived RFs were reactive with only one of the
threeVH subgroup-specific antisera (IgM-RF Gol was nonreactive). Most impor-
tantly, all CAs were recognized by the antibodies against subgroup IIH chain. In
contrast, the great proportion (23:30, 77%) ofHumkv325-RFs useVHIH chains,
while a minority have H chains from the VHII (4:30, 13%), or VHIII subgroups
(2 :30, 7%a) . By xsquare analysis, this association of subgroup IIH chains with CAs,
compared with RFs, is highly significant (b < 0.001) .2364 SILVERMAN ET AL.
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TABLE I
Immunoblotting Results of 10 CAs and 30 RFs
These L chains have been demonstrated to be Humkv325 derived based on comparison of
the complete amino acid sequences and serologic reactivity, and the NHz-terminal sequence
of AJ has been reported to residue 30 (2,6,8,15, and F. Goíii, submitted for publication).
SCH is an IgA, all others are IgM .
L chain reactivity H chain reactivity
Autoantibody
Anti-VkIIl
subgroup
Anti-
PSL2
Anti-
PSL3
17 .109
CRI
Anti-VHI
subgroup
Anti-VHII
subgroup
Anti-VHIII
subgroup
IgM-VkIII CAs
AJ* + + - - - + -
BAT + + + + - + -
BON + + - - - + -
HIG + + - - - + -
KAU* + + + - - + -
LEA + + - - - + -
PER + + - - - + -
POS* + + + - - + -
SOC* + + - - - + -
TRI* + + + - - + -
0 10(100%) 0
Humkv325-derived RFs
AND + + - + + - -
ANG* + + + - + - -
ARL + + - + + - -
BEL + + + - + - -
BLO + + - + + - -
BOR* + + + + + - -
BUS + + + ND - + -
CIN* + + + ND + - -
CSA* + + + ND - + -
CUR* + + + + - + -
DAQ + + + ND + - -
DRI + + + + + - -
FLO* + + + + + - -
FRA + + + + + - -
GAL + - + ND + - -
GAR* + + + + + - -
GLO* + + + + - - +
GOL* + + + - - - -
GOT* + + + + - + -
JAN + + + + + - -
KAS* + + + + + - -
KOK + + + + + - -
MCD + + + + + - -
NEU* + + + - + - -
PAL(m) + + + + + - -
PAY* + + + ND - - +
SAR + + + ND + - -
SCHI + + + + + - -
SIE* + + + + + - -
WOL* + + - - + - -
23 (77%) 4 (137o) 2 (7%)SILVERMAN ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
2365
Although the VkIII subgroup represents only 137o ofx chains in sera (1), these
L chains are used in >60% of IgM-RFs (11), and apparently by most IgM CAs
directed against the I antigen. As shown here, the majority (77%) ofthe Humkv325-
derived RFs use Hchains ofthe VHI subgroup, while all VkIII CAs use subgroup
II H chains. Other experiments have shown that VkIIIb mAbs that bind to low-
densitylipoprotein, or intermediate filaments, use Hchains ofthe VHIII subgroup
(G. Silverman and I? Goni, unpublished data). Finally, none ofthese autoantibodies
display a pattern of Hchain use comparable with VkIII paraproteins ofunknown
specificity (VHI, 39%; VHII, 17%; and VHIII, 43%) (7); nor does the utilization
ofthe VH subgroupsby thetwo autoantibodies reflect current estimates ofVH gene
complexity (12).
These experiments are the first to demonstrate a relationship between H chain
variable region subgroup utilization and autoantibody specificity. The results pro-
vide support to the hypothesis that the binding specificity ofmany IgM VkIIIb au-
toantibodies is influenced strongly by the H chain partner.
Although 4:30 IgM-RFs usehuman subgroup II Hchains, thesemay derive from
a different VH gene subset than CAs. In this regard, the genes encoding the VHII
protein subgroup have recently been subdivided into at least two distinct VH gene
families, designated VHII andVHIV (10), andarelatedsingle member gene family,
VH6, has also been reported (12). Members ofthese VH gene families have related
nonidentical framework regions, but diverse CDRs, and we are currently working
to develop serologic reagents that can discriminate them.
It is possible that the prominent patterns ofVgene use by the human IgM auto-
antibodies that are associated withcertainlymphoproliferative disorders areareflection
of an ordered pattern of gene expression during B cell development. Recently,
Schroeder et al. (13) have demonstrated restricted VH gene use by B cells in 120-d
human fetalliver. Oneofthesegenes (30P1) is nearly identical to those used by anti-
DNA antibodies that express the 16:6 lupus idiotype (14). Perhaps early B cells that
utilize VkIII L chains are preferentially expanded, because they produce a func-
tional antigen receptor when paired with several different germline-encoded HC
partners. According to this hypothesis, the interaction ofimmature B cells with au-
toantigens in the spleen, peyer's patches, or other lymphoid organs may promote
the early expansion ofthe B cell repertoire.
Summary
Using a panel ofantibodies specific for H and Lchain variable region subgroups,
a panel of human monoclonal cold agglutinin (CA) and rheumatoid factor (RF)
autoantibodies were analyzed. The vast majority ofthe two types ofautoantibodies
utilized VkIII L chains, many ofwhich probably derive from the Humkv325 gene.
However, while most RFs (77%) utilized VHI H chains, all the CAs used VHII
subgroupHchains. These results are consistent with amodelofautoantibody gener-
ation, wherein binding specificity is H chain defined in a set ofantibodies that use
a multipotential L chain.
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